Header Logo

Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis.

Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis. iScience. 2021 Jan 22; 24(1):101902.

View in: PubMed